Foster Mohale, spokesperson for South Africa's national Department of Health, said that as of 23 August there had been 3,641 initiations of lenacapavir across 22 government clinics offering the injection in the Western Cape province. ^[1] Due to severely constrained supply, lenacapavir is currently being rolled out to only 360 health facilities across six provinces in South Africa. ^[2] Nationally, the number of lenacapavir initiations stood at 47,934 as of the reporting period. ^[3] The rollout strategy specifically targets adolescent girls and young women, women of reproductive age, and pregnant or breastfeeding women at substantial risk of HIV acquisition. ^[4] Olwam Plaatjie, a 20-year-old woman from Crossroads in Cape Town, told Spotlight she switched from the two-monthly cabotegravir HIV prevention injection to the six-monthly injectable lenacapavir, despite small nodules forming at the two injection sites on her abdomen. ^[5]